Angela Watson, MD
Obstetrics & Gynecology · Plano, TXNPI 1841493871
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,400 of the $6,571 with a category attached, or 67.0%. Mimedx Group, Inc. accounts for 67.0% of it on its own, with 33 other manufacturers making up the rest. 2025 is the largest year on record at $2,897, more than ten times the $281 reported in 2019.
Across 121 payments — averaging $54.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mimedx Group, Inc.$4K
- Pfizer$335
- AbbVie$209
- Hologic Sales And Service, LLC$202
- Aspira Women's Health Inc$125
- Bayer$122
- plus $1K from 28 others
What the payments were for
- Consulting fees$4,40067%
- Food & beverage$2,17133%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mimedx Group, Inc. | 14 | $4,400 |
| Pfizer | 18 | $335 |
| AbbVie | 12 | $209 |
| Hologic Sales And Service, LLC | 6 | $202 |
| Aspira Women's Health Inc | 2 | $125 |
| Bayer | 6 | $122 |
| Exeltis, USA Inc. | 4 | $103 |
| Astellas Pharma US Inc | 4 | $71 |
| Mayne Pharma Commercial LLC | 6 | $66 |
| Millicent US Inc | 3 | $60 |
| Organon | 3 | $59 |
| Meditrina | 3 | $58 |
| Innovation Technologies Inc | 2 | $58 |
| Sumitomo Pharma America, Inc. | 3 | $57 |
| Sage Therapeutics, LLC | 3 | $55 |
| Avion Pharmaceuticals | 4 | $52 |
| Acella Pharmaceuticals, LLC | 3 | $49 |
| Avanos Medical | 2 | $49 |
| Minerva Surgical, Inc | 3 | $41 |
| Johnson & Johnson | 2 | $39 |
| Novo Nordisk | 2 | $37 |
| Channel Medsystems, Inc. | 1 | $36 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Medtronic | 1 | $32 |
| Pacira Pharmaceuticals Incorporated | 1 | $31 |
| Coopersurgical, Inc. | 2 | $27 |
| Therapeuticsmd, Inc. | 2 | $27 |
| Myovant Sciences Inc. | 1 | $23 |
| Davol Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $19 |
| Mycovia Pharmaceuticals, Inc. | 1 | $18 |
| Integra Lifesciences Corporation | 1 | $16 |
| Convatec Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOVINE COLLAGEN$600
How this compares
$6,571 in reported general payments places this provider in the 85th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 48 | $1,818 |
| ProgesteroneProgesterone, Micronized | 13 | $626 |
| Levothyroxine Sodium | 11 | $30 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Plano
- Elizabeth CoronadoPlano$155K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.